Search Results

GB virus type C interactions with HIV: the role of envelope glycoproteins

Authors: Mohr, Emma L.; Stapleton, Jack T.

Source: Journal of Viral Hepatitis, Volume 16, Number 11, November 2009 , pp. 757-768(12)

Publisher: Blackwell Publishing

Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells

Authors: Zhou, Jiehua; Swiderski, Piotr; Li, Haitang; Zhang, Jane; Neff, C. Preston; Akkina, Ramesh; Rossi, John J.

Source: Nucleic Acids Research, Volume 37, Number 9, 19 May 2009 , pp. 3094-3109(16)

Publisher: Oxford University Press

Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes

Authors: Guillen, Jaime; De Almeida, Rodrigo; Prieto, Manuel; Villalain, Jose

Source: Molecular Membrane Biology, Volume 26, Number 4, March 2009 , pp. 236-248(13)

Publisher: Informa Healthcare

Detection of the Active Components of Calf Thymus Nuclear Proteins (TNP), Histones that are Binding with High Affinity to HIV-1 Envelope Proteins and CD4 Molecules

Authors: Mamikonyan, Grigor; Kiyatkin, Anatoly; Movsesyan, Nina; Mkrtichyan, Mikayel; Ghochikyan, Anahit; Petrushina, Irina; Hwang, Jimmy; Ichim, Thomas E.; Keledjian, Haig; Agadjanyan, Michael G.

Source: Current HIV Research, Volume 6, Number 4, July 2008 , pp. 318-326(9)

Publisher: Bentham Science Publishers

Multi-Functional Anti-HIV Agents Based on Amino Acid Sequences Present in Serpin C-Terminal Peptides

Author: Congote, L. F.

Source: Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Volume 7, Number 2, April 2008 , pp. 126-133(8)

Publisher: Bentham Science Publishers

HIV Entry Inhibitors Targeting gp41: From Polypeptides to Small-Molecule Compounds

Authors: Liu, Shuwen; Wu, Shuguang; Jiang, Shibo

Source: Current Pharmaceutical Design, Volume 13, Number 2, January 2007 , pp. 143-162(20)

Publisher: Bentham Science Publishers

Rational Modifications of HIV-1 Envelope Glycoproteins for Immunogen Design

Authors: Phogat, S.; Wyatt, R.

Source: Current Pharmaceutical Design, Volume 13, Number 2, January 2007 , pp. 213-227(15)

Publisher: Bentham Science Publishers

HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41

Authors: Rey-Cuillé, Marie-Anne; Svab, Josette; Benferhat, Rima; Krust, Bernard; Briand, Jean-Paul; Muller, Sylviane; Hovanessian, Ara G.

Source: Journal of Pharmacy and Pharmacology, Volume 58, Number 6, June 2006 , pp. 759-767(9)

Publisher: Pharmaceutical Press

Anti-HIV Therapy: Current and Future Directions

Authors: Agrawal, Lokesh; Lu, Xihua; Jin, Qingwen; Alkhatib, Ghalib

Source: Current Pharmaceutical Design, Volume 12, Number 16, June 2006 , pp. 2031-2055(25)

Publisher: Bentham Science Publishers

Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1

Author: Debnath, Asim K

Source: Expert Opinion on Investigational Drugs, Volume 15, Number 5, May 2006 , pp. 465-478(14)

Publisher: Informa Healthcare

Advances in HIV-1 Entry Inhibitors: Strategies to Interfere with Receptor and CoReceptor Engagement

Author: Markovic, Ingrid

Source: Current Pharmaceutical Design, Volume 12, Number 9, March 2006 , pp. 1105-1119(15)

Publisher: Bentham Science Publishers

Editorial [Hot Topic:Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) (Guest Editor: Christopher J. Burns)]

Author: Burns Christopher J.

Source: Current Medicinal Chemistry - Anti-Infective Agents, Volume 4, Number 2, April 2005 , pp. 97-97(1)

Publisher: Bentham Science Publishers

Repeated epitope in the recombinant epitope-peptide could enhance ELDKWA-epitope-specific antibody response

Authors: Zuqiang, Liu; Zuquang, Wang; Yinghua, Chen

Source: Progress in Natural Science, Volume 15, Number 1, January 2005 , pp. 89-92(4)

Publisher: Taylor and Francis Ltd

Molecular Mechanisms of Resistance to Nucleoside Analogue Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase

Authors: Menendez-Arias, Luis; Matamoros, Tania; Deval, Jerome; Canard, Bruno

Source: Drug Design Reviews - Online, Volume 2, Number 2, March 2005 , pp. 101-113(13)

Publisher: Bentham Science Publishers

Nucleotide sequence and molecular characterization of the structural glycoprotein gp41 gene homologue of Spodoptera litura nucleopolyhedrosis virus (SpltNPV-I)

Authors: Monika Jain; Rakha Das

Source: Molecular Biology Reports, Volume 31, Number 4, January 2005 , pp. 231-239(9)

Publisher: Springer

Structure and membrane interaction of the internal fusion peptide of avian sarcoma leukosis virus

Authors: Cheng, Shu-Fang; Wu, Cheng-Wei; Kantchev, Eric Assen B; Chang, Ding-Kwo

Source: FEBS Journal, Volume 271, Numbers 23-24, December 2004 , pp. 4725-4736(12)

Publisher: Blackwell Publishing

Resistance to enfuvirtide, the first HIV fusion inhibitor

Authors: Michael L. Greenberg; Nick Cammack

Source: Journal of Antimicrobial Chemotherapy, Volume 54, Number 2, 12 August 2004 , pp. 333-340(8)

Publisher: Oxford University Press

Recent Advances in Understanding the Molecular Mechanisms of HIV-1 Entry and Fusion: Revisiting Current Targets and Considering New Options for Therapeutic Intervention

Authors: Markovic I.; Clouse K.A.

Source: Current HIV Research, Volume 2, Number 3, July 2004 , pp. 223-234(12)

Publisher: Bentham Science Publishers

Preface [Hot Topic: HIV Entry Inhibitors Executive Editor: Shibo Jiang ]

Author: Jiang, Shibo

Source: Current Pharmaceutical Design, Volume 10, Number 15, June 2004 , pp. i-ii(1)

Publisher: Bentham Science Publishers

High Throughput Screening and Characterization of HIV-1 Entry Inhibitors Targeting gp41: Theories and Techniques

Authors: Liu, Shuwen; Jiang, Shibo

Source: Current Pharmaceutical Design, Volume 10, Number 15, June 2004 , pp. 1827-1843(17)

Publisher: Bentham Science Publishers